The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Astellas' 2013 sales performance.
Pfizer/Astellas’ prostate cancer treatment Xtandi (enzalutamide) is also a prominent market competitor, with approvals in nmCRPC, mCSPC and metastatic castration-resistant prostate cancer (mCRPC).
Audentes, which was bought by Japanese pharma company Astellas last year, was forced to put the ASPIRO trial on hold in June after disclosing the first two patient deaths.
However, following further discussions with Astellas, NICE has recommended Xospata monotherapy for treating adult patients with relapsed or refractory FLT3-positive AML. ... no longer works or they relapse,” said Jackie Williams, general manager for
Uniting Employees Behind Astellas’ Scientific Innovation Approach: The Scientific Innovation Narrative. ... Uniting Employees Behind Astellas’ Scientific Innovation Approach: The Scientific Innovation Narrative - by Arc Bio Communications for
Uniting Employees Behind Astellas’ Scientific Innovation Approach: The Scientific Innovation Narrative. ... Uniting Employees Behind Astellas’ Scientific Innovation Approach: The Scientific Innovation Narrative - by Arc Bio Communications for
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...